➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Johnson and Johnson
Moodys
Mallinckrodt
Dow

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FINASTERIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Finasteride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status Cancer and Leukemia Group B Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status Eastern Cooperative Oncology Group Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status European Organisation for Research and Treatment of Cancer - EORTC Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status National Cancer Institute (NCI) Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status NCIC Clinical Trials Group Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status Southwest Oncology Group Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00003323 Hormone Therapy in Treating Patients With Prostate Cancer Completed National Cancer Institute (NCI) Phase 2 1998-05-01 RATIONALE: Male hormones can stimulate the growth of prostate cancer cells. Hormone therapy using flutamide and finasteride may fight prostate cancer by reducing the production of male hormones. PURPOSE: Phase II trial to study the effectiveness of flutamide and finasteride in treating prostate cancer patients with high PSA levels who were previously treated with radiation therapy or radical prostatectomy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Finasteride

Condition Name

Condition Name for Finasteride
Intervention Trials
Benign Prostatic Hyperplasia 11
Healthy 10
Androgenetic Alopecia 8
Prostate Cancer 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Finasteride
Intervention Trials
Prostatic Hyperplasia 22
Hyperplasia 20
Alopecia 12
Alopecia Areata 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Finasteride

Trials by Country

Trials by Country for Finasteride
Location Trials
United States 116
Canada 19
Korea, Republic of 8
Mexico 6
Argentina 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Finasteride
Location Trials
Texas 10
Florida 8
California 7
Maryland 6
Illinois 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Finasteride

Clinical Trial Phase

Clinical Trial Phase for Finasteride
Clinical Trial Phase Trials
Phase 4 9
Phase 3 16
Phase 2 15
[disabled in preview] 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Finasteride
Clinical Trial Phase Trials
Completed 39
Recruiting 7
Not yet recruiting 6
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Finasteride

Sponsor Name

Sponsor Name for Finasteride
Sponsor Trials
GlaxoSmithKline 5
Dr. Reddy's Laboratories Limited 4
Merck Sharp & Dohme Corp. 4
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Finasteride
Sponsor Trials
Other 43
Industry 42
NIH 16
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Boehringer Ingelheim
Baxter
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.